Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types - Wikidata - awgldk - TriplyDB

Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types

Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types

http://www.wikidata.org/entity/Q28248276

about

Epigenetics of cervical cancer. An overview and therapeutic perspectives Cancer diagnostic classifiers based on quantitative DNA methylation Molecular mechanisms of HPV mediated neoplastic progression Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update Concomitant promoter methylation of multiple genes in lung adenocarcinomas from current, former and never smokers DNA methylation profile of 28 potential marker loci in malignant mesothelioma Whole blood DNA aberrant methylation in pancreatic adenocarcinoma shows association with the course of the disease: a pilot study Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression.Discovery of DNA methylation markers in cervical cancer using relaxation ranking.mRNA expression, functional profiling and multivariate classification of colon biopsy specimen by cDNA overall glass microarray Identification of novel methylation markers in hepatocellular carcinoma using a methylation array Cross-platform array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as genes frequently silenced by methylation in melanoma.Association of TNFRSF10D DNA-methylation with the survival of melanoma patients.TRAIL in cancer therapy: present and future challenges.Investigation of DNA damage response and apoptotic gene methylation pattern in sporadic breast tumors using high throughput quantitative DNA methylation analysis technology.DNA methylation profiling across the spectrum of HPV-associated anal squamous neoplasia.Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer CpG-island methylation study of liver fluke-related cholangiocarcinoma.Systematic detection of putative tumor suppressor genes through the combined use of exome and transcriptome sequencing Aberrant DNA methylation and prostate cancer.Targeted ovarian cancer treatment: the TRAILs of resistance.Epigenomics and ovarian carcinoma.Epigenetic mechanisms in virus-induced tumorigenesis.Application of a methylation gene panel by quantitative PCR for lung cancers.Epigenetic alterations in preneoplastic and neoplastic lesions of the cervix GATA4 and DcR1 methylation in glioblastomas.TRAIL receptor-targeted therapeutics: resistance mechanisms and strategies to avoid them.TNFRSF10C copy number variation is associated with metastatic colorectal cancer.Evaluation of candidate methylation markers to detect cervical neoplasia Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survival.Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science.Expression of cancer-associated molecules in malignant mesothelioma New diagnostic and molecular characteristics of malignant mesothelioma.Expression profiling after induction of demethylation in MCF-7 breast cancer cells identifies involvement of TNF-α mediated cancer pathways.Genetic and epigenetic inactivation of TNFRSF10C in human prostate cancer.Epigenetic regulation of cell life and death decisions and deregulation in cancer.Promoter hypermethylation in prostate cancer.Hypermethylation in bladder cancer: biological pathways and translational applications.The significance of the senescence pathway in breast cancer progression.

P2860

Q24812104-66C56008-B7E5-4A80-BEB6-42EE85657135 Q27012960-8753204E-96D9-4672-AA9A-2EF355331C2E Q28070323-DAE9E450-4359-4168-87D8-54F5F36B84B5 Q28385230-C3690CF7-355B-42C5-A525-E2D8FADE33A8 Q28386334-732D282F-F422-4AF4-9897-BC9426C07C74 Q28389551-8F370516-9D31-4AB5-82CF-EEA629F24BF8 Q28391214-7634F021-AC59-4A28-9141-A2ACE4563528 Q28729757-6D5E6C5E-8D08-4E12-BD97-DD1F2831AEC4 Q33288897-01B1429E-D751-4F2D-AC1C-8F7D27731DC7 Q33386224-8C064E18-35D4-4571-90F2-551103C1DB7E Q33865879-B9BC8FC6-7CAC-476F-8628-6BB012781443 Q34014744-0CBF29DB-E0F4-4587-A152-1E4E7BFD907E Q34058385-A28BF7FD-7607-4ECC-94E8-286499DECDD4 Q34072329-AC6BC75D-4474-4BAD-A886-F1055EFBAEDE Q34291312-68144C3B-3D8F-4C20-B76B-1D41227F3CE6 Q34419090-AD550CAB-6B09-4258-BD7A-7C2DF9A48802 Q34505483-97A7DBC6-4877-4831-A103-EBB293A9DFF6 Q34711457-90B5B8F7-B2B5-4ECB-B9F9-D9252D02AFDC Q34806684-20627687-0490-4C57-92D6-484236DE594B Q35167227-28AE9B87-6D05-4201-AAE4-2BDB14A31F88 Q35560819-EF3AEFC3-4636-41A2-9E13-AB7EB874C2B5 Q35609438-AFA90E6C-396E-487D-96FD-285E2AF9F2A0 Q35636575-5936598C-BFC5-4FD9-B26D-29720D42C107 Q36001887-F9A55688-EB51-4C17-A4E8-F77EF3692110 Q36047712-989661DC-FE93-4C75-A4D3-703B835CBE6D Q36412445-754F7DF7-EDB8-4149-ADDF-80DC14AD0962 Q36690240-0673C994-44B3-4A0E-A041-F4DC720929CE Q36731174-0DB32E94-8C27-481B-8D24-FD8594FC9D2A Q36936939-E91A3A0B-E3D1-4B63-A1CE-841E1943483E Q36951370-4E52CD98-3F5F-4B0E-80C8-5A49B5898B7D Q36960662-D903B9FB-0F91-489A-8B4A-CA330109288D Q37170521-E38B6A13-B253-4104-8465-3AF6B119062C Q37281015-49F2B03A-7CB6-497A-9A34-9584F79DD469 Q37360580-E1073A7B-3E59-42A8-B86A-BFA755FC071D Q37461534-874F2628-88FC-4E0A-8609-9D36CEEA94BC Q37481462-DB39B028-7D40-49CF-8745-27C1581FF4FE Q37785993-65FAEE60-67AD-4247-BEFB-F632C7B419AC Q37791396-8F2BD564-FC2A-42BD-B6D4-4C38A00151FC Q37978544-7A8CC986-156D-41E0-8E1C-4E4B6A6B4E74 Q38094150-8AAEEDFA-0499-497D-A85D-CB28A56B3AD5

P2860

Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types

http://www.wikidata.org/entity/Q28248276

description

2004 nî lūn-bûn

@nan

2004 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types

@ast

Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types

@en

Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types

@nl

type

label

Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types

@ast

Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types

@en

Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types

@nl

prefLabel

Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types

@ast

Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types

@en

Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types

@nl

P1433

Q28248276-AEB90BC5-5CD6-4065-A122-D131B0380BE4

P1476

Q28248276-E0D9A731-FFED-4ACD-88BD-44684C3AD030

P2093

Q28248276-1571BF3E-E9D7-488C-B01E-DE3461396942

Q28248276-367DF841-6950-4EAF-A923-B7D7C6C018BB

Q28248276-3BA3ADA5-9DFB-4BA1-94F0-7903765CABE7

Q28248276-5B36DC6B-1104-4F00-B54A-88D2A623E1E7

Q28248276-716F7E2B-E966-4BCE-856F-D16622504937

Q28248276-78A02614-6D14-4DD1-8A56-081E14519A6E

Q28248276-82AFDBDB-DEFF-43D1-9659-631376A805B2

Q28248276-83C0A64D-A1B9-452A-A031-8A4CBBBC86EF

Q28248276-BA499C3F-6122-4C02-BBD5-5A44EBFA2F4C

Q28248276-DAFAAF50-E6D1-4E48-A0C2-66E139F2C25D

P2860

Q28248276-AA57A32A-9458-4EB7-A974-A24857295292

P304

Q28248276-06F51137-4FF2-44A9-A91A-417A8A997E1A

P31

Q28248276-F03C74C5-D00F-4276-81E8-C47D0CAABD55

P356

Q28248276-4BBD8F90-E984-4CAE-A8D4-B7F5E6FCE233

P407

Q28248276-8EEE37E1-5B1D-4B81-9D34-DAE5D5EF30E3

P433

Q28248276-D21792F1-EB06-450B-A20A-35ED9FDADED4

P478

Q28248276-03F0A60D-C86E-47EA-B55C-8F1D7648159A

P577

Q28248276-EE4B3E95-3F60-4D88-993E-D7E7806A13D0

P5875

Q28248276-104FA973-5DC6-4794-B724-638DD6DE6445

P698

Q28248276-6F642421-F350-42E5-AD9B-160C47447521

P356

P1433

International Journal of Cancer

P1476

Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types

@en

P2093

Adi F Gazdar

http://www.w3.org/2001/XMLSchema#string

Gunjan Parikh

http://www.w3.org/2001/XMLSchema#string

Harvey I Pass

http://www.w3.org/2001/XMLSchema#string

Hisayuki Shigematsu

http://www.w3.org/2001/XMLSchema#string

Jyotsna Reddy

http://www.w3.org/2001/XMLSchema#string

Kiyomi O Toyooka

http://www.w3.org/2001/XMLSchema#string

Kuniharu Miyajima

http://www.w3.org/2001/XMLSchema#string

Makoto Suzuki

http://www.w3.org/2001/XMLSchema#string

Narayan Shivapurkar

http://www.w3.org/2001/XMLSchema#string

Preet M Chaudhary

http://www.w3.org/2001/XMLSchema#string

P2860

Fas ligand-induced c-Jun kinase activation in lymphoid cells requires extensive receptor aggregation but is independent of DAXX, and Fas-mediated cell death does not involve DAXX, RIP, or RAIDD.

P304

786-92

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.20041

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P577

2004-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5364161

http://www.w3.org/2001/XMLSchema#string

P698

14999791

http://www.w3.org/2001/XMLSchema#string